Objective:

To evaluate the efficacy and safety of faricimab in patients with polypoidal choroidal vasculopathy (PCV).

Key Findings:

• Add brief definitions for BCVA and CST.

Interpretation:

Emphasize the clinical significance of the results.

Limitations:

• Specify how the small sample size affects the findings.

Conclusion:

Highlight the importance of ongoing research.